About Jimena Vicencio
Articles by Jimena Vicencio, MD
Is There A Connection Between Lenalidomide and Second Cancers in Multiple Myeloma?Apr 15, 2026
Pilates for Strength and Mobility: What People With Cancer Need to KnowApr 13, 2026
Strength Training for People with CancerApr 09, 2026
Why Are People Dropping Red Meat?: Lowering Cancer Risk through Dietary ChangesApr 09, 2026
New Research Milestone: HealthTree Community Data Powers Study in Blood Cancer JournalApr 07, 2026
Using Whole Genome Sequencing to Personalize Myeloma CareApr 06, 2026
Why MRD and WGS Are Game Changers for Myeloma TreatmentMar 27, 2026
New Research Explores Targeted Therapy for ASXL1-Mutant CMMLMar 25, 2026
Myeloma Awareness Month: Patients are Living Longer Thanks to New TreatmentsMar 25, 2026
What are CELMoDs for Multiple Myeloma? : Mezigdomide and Iberdomide ExplainedMar 24, 2026
Key Advances in High-Risk Multiple MyelomaMar 20, 2026
Emerging Drug Classes in MyelomaMar 20, 2026
Better Sleep With Cancer: Understanding Sleep Problems and How to Rest BetterMar 16, 2026
Remote Check-Ups Could Prevent Infection-Related Hospitalizations for Blood Cancer PatientsMar 16, 2026
Does Donor Age Matter for Stem Cell Transplant Success? What the Latest Research SaysMar 16, 2026
A New Approach to CAR-T Therapy: Creating Cancer-Fighting Cells Directly Inside the BodyMar 13, 2026
Can Menin Inhibitors Become a New Treatment Option for Myeloproliferative Neoplasms?Mar 13, 2026
Why Are Infections Common In Myeloma As It Progresses?Mar 12, 2026
A New Target in TP53-Mutated Blood Cancers: Could Blocking PLEK2 Slow Disease Progression?Mar 12, 2026
Could A Common Bacteria Treat Cancer?Mar 12, 2026
New Research Identifies Unique Weaknesses in High-Risk Myelodysplastic Syndromes (MDS)Mar 11, 2026
The Approved Medication That Could Boost CAR-TMar 09, 2026
Researchers Identify Weakness in Blood Cancer Cells with U2AF1 S34 Mutation That Could Lead to New TreatmentsMar 04, 2026
Rapid CAR-T Expansion Linked to Delayed Neurotoxicity in MyelomaMar 02, 2026
